Opioid agonist therapy supports are available through the GPSC and Pharmacare to address pain management and opioid prescribing. These include:

  • GPSC Fee code G14074 – GP Unattached Complex/High Needs Patient Attachment Fee: This fee compensates for the time, intensity and complexity of integrating a new patient with high needs, including mental health and/or substance use patients, into a family physician’s practice. For more information, please refer to the GPSC's attachment billing guide.
  • GPSC Fee code G14043 – GP Mental Health Planning Fee: This fee is payable upon the development and documentation of a patient’s Mental Health Plan for patients resident in the community. Patients must have a confirmed Axis I diagnosis of sufficient severity and acuity to warrant the development of a management plan, and both Alcohol Dependency (303) and Substance Abuse (non-nicotine) (304) qualify as Axis I diagnoses. If this fee is billed for a patient with either Alcohol or Substance Abuse issues, all other criteria of the fee must be met. For more information, please refer to the GPSC's mental health billing guide.
  • Effective February 1, 2017, PharmaCare will cover Methadose™ for maintenance and buprenorphine/naloxone under its Psychiatric Medications Plan (Plan G). By covering these drugs under Plan G, 100% PharmaCare coverage may be available to more individuals with lower incomes. For more information, please refer to:

As well, doctors can access available supports created by local divisions and the GPSC that are summarized here.

These resources help doctors to manage substance use issues in their own communities, and to comply with opioid prescribing standards announced by the BC College of Physician and Surgeons in 2016.